市場調査レポート
商品コード
1074736

ファーマコビジランス・医薬品安全性ソフトウェアの世界市場:2022年~2026年

Global Pharmacovigilance and Drug Safety Software Market 2022-2026

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=128.03円
ファーマコビジランス・医薬品安全性ソフトウェアの世界市場:2022年~2026年
出版日: 2022年05月06日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のファーマコビジランス・医薬品安全性ソフトウェアの市場規模は、2022年~2026年の間に7,274万米ドルの増加が見込まれ、予測期間中にCAGRで7.11%の成長が予測されています。

市場は、薬物有害事象の発生率の上昇、政府の有利な規制や政策、新しい分子やバイオシミラーの承認の増加によって牽引されています。

当レポートでは、世界のファーマコビジランス・医薬品安全性ソフトウェア市場について調査分析し、全体的な分析、市場規模と予測、動向、成長促進要因、課題、約25社のベンダーを網羅したベンダー分析を提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場のエコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模:2021年
  • 市場の見通し:2021年~2026年の予測

第4章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競合企業の脅威
  • 市況

第5章 市場セグメンテーション:エンドユーザー別

  • 市場セグメント
  • 比較:エンドユーザー別
  • 製薬およびバイオテクノロジー企業 - 市場規模と予測:2021年~2026年
  • 医薬品開発受託機関 - 市場規模と予測:2021年~2026年
  • ビジネスプロセスアウトソーシング - 市場規模と予測:2021年~2026年
  • 市場機会:エンドユーザー別

第6章 顧客情勢

  • 顧客情勢の概要

第7章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米 - 市場規模と予測:2021年~2026年
  • 欧州 - 市場規模と予測:2021年~2026年
  • アジア - 市場規模と予測:2021年~2026年
  • その他の地域(ROW) - 市場規模と予測:2021年~2026年
  • 米国 - 市場規模と予測:2021年~2026年
  • フランス - 市場規模と予測:2021年~2026年
  • ドイツ - 市場規模と予測:2021年~2026年
  • 日本 - 市場規模と予測:2021年~2026年
  • 中国 - 市場規模と予測:2021年~2026年
  • 市場機会:地域情勢別

第8章 促進要因、課題、動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第9章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第10章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • AB Cube SARL
  • ArisGlobal LLC
  • BaseCon AS
  • Ennov
  • EXTEDO GmbH
  • Honeywell International Inc.
  • Indegene Pvt. Ltd.
  • Oracle Corp.
  • Sarjen Systems Pvt. Ltd.
  • United BioSource LLC

第11章 付録

目次
Product Code: IRTNTR70377

Technavio has been monitoring the pharmacovigilance and drug safety software market and it is poised to grow by $ 72.74 mn during 2022-2026, accelerating at a CAGR of 7.11% during the forecast period. Our report on the pharmacovigilance and drug safety software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising incidence rates of adverse drug events, favorable government regulations and policies, and increasing approvals of new molecules and biosimilars.

The pharmacovigilance and drug safety software market analysis includes the end-user segment and geographic landscape.

Technavio's pharmacovigilance and drug safety software market is segmented as below:

By End-user

  • Pharmaceutical and biotechnology companies
  • Contract research organization
  • Business process outsourcing

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the integration of AI in pharmacovigilance as one of the prime reasons driving the pharmacovigilance and drug safety software market growth during the next few years. Also, outsourcing pharmacovigilance and drug safety research to CROs and extensive adoption of cloud technologies in pharmaceutical manufacturing and testing will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on pharmacovigilance and drug safety software market covers the following areas:

  • Pharmacovigilance and drug safety software market sizing
  • Pharmacovigilance and drug safety software market forecast
  • Pharmacovigilance and drug safety software market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmacovigilance and drug safety software market vendors that include AB Cube SARL, Accenture Plc, Advera Health Analytics Inc., ArisGlobal LLC, BaseCon AS, Clarivate PLC, Cognizant Technology Solutions Corp., Ennov, EXTEDO GmbH, Honeywell International Inc., Indegene Pvt. Ltd., IQVIA Holdings Inc., Max Application Srl, Oracle Corp., Pegasystems Inc., Sarjen Systems Pvt. Ltd., United BioSource LLC, Veeva Systems Inc., and Wipro Ltd. Also, the pharmacovigilance and drug safety software market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user

  • 5.1 Market segments
  • Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
  • 5.2 Comparison by End-user
  • Exhibit 26: Chart on Comparison by End-user
  • Exhibit 27: Data Table on Comparison by End-user
  • 5.3 Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
  • 5.4 Contract research organization - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Contract research organization - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Contract research organization - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Contract research organization - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Contract research organization - Year-over-year growth 2021-2026 (%)
  • 5.5 Business process outsourcing - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Business process outsourcing - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Business process outsourcing - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Business process outsourcing - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Business process outsourcing - Year-over-year growth 2021-2026 (%)
  • 5.6 Market opportunity by End-user
  • Exhibit 40: Market opportunity by End-user ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 44: Chart on Geographic comparison
  • Exhibit 45: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 France - Market size and forecast 2021-2026
  • Exhibit 66: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on France - Year-over-year growth 2021-2026 (%)
  • 7.9 Germany - Market size and forecast 2021-2026
  • Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.10 Japan - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • 7.11 China - Market size and forecast 2021-2026
  • Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 85: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 86: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 87: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 88: Matrix on vendor position and classification
  • 10.3 AB Cube SARL
  • Exhibit 89: AB Cube SARL - Overview
  • Exhibit 90: AB Cube SARL - Product / Service
  • Exhibit 91: AB Cube SARL - Key offerings
  • 10.4 ArisGlobal LLC
  • Exhibit 92: ArisGlobal LLC - Overview
  • Exhibit 93: ArisGlobal LLC - Product / Service
  • Exhibit 94: ArisGlobal LLC - Key offerings
  • 10.5 BaseCon AS
  • Exhibit 95: BaseCon AS - Overview
  • Exhibit 96: BaseCon AS - Product / Service
  • Exhibit 97: BaseCon AS - Key offerings
  • 10.6 Ennov
  • Exhibit 98: Ennov - Overview
  • Exhibit 99: Ennov - Product / Service
  • Exhibit 100: Ennov - Key news
  • Exhibit 101: Ennov - Key offerings
  • 10.7 EXTEDO GmbH
  • Exhibit 102: EXTEDO GmbH - Overview
  • Exhibit 103: EXTEDO GmbH - Product / Service
  • Exhibit 104: EXTEDO GmbH - Key news
  • Exhibit 105: EXTEDO GmbH - Key offerings
  • 10.8 Honeywell International Inc.
  • Exhibit 106: Honeywell International Inc. - Overview
  • Exhibit 107: Honeywell International Inc. - Business segments
  • Exhibit 108: Honeywell International Inc. - Key news
  • Exhibit 109: Honeywell International Inc. - Key offerings
  • Exhibit 110: Honeywell International Inc. - Segment focus
  • 10.9 Indegene Pvt. Ltd.
  • Exhibit 111: Indegene Pvt. Ltd. - Overview
  • Exhibit 112: Indegene Pvt. Ltd. - Product / Service
  • Exhibit 113: Indegene Pvt. Ltd. - Key news
  • Exhibit 114: Indegene Pvt. Ltd. - Key offerings
  • 10.10 Oracle Corp.
  • Exhibit 115: Oracle Corp. - Overview
  • Exhibit 116: Oracle Corp. - Business segments
  • Exhibit 117: Oracle Corp. - Key news
  • Exhibit 118: Oracle Corp. - Key offerings
  • Exhibit 119: Oracle Corp. - Segment focus
  • 10.11 Sarjen Systems Pvt. Ltd.
  • Exhibit 120: Sarjen Systems Pvt. Ltd. - Overview
  • Exhibit 121: Sarjen Systems Pvt. Ltd. - Product / Service
  • Exhibit 122: Sarjen Systems Pvt. Ltd. - Key offerings
  • 10.12 United BioSource LLC
  • Exhibit 123: United BioSource LLC - Overview
  • Exhibit 124: United BioSource LLC - Product / Service
  • Exhibit 125: United BioSource LLC - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 126: Inclusions checklist
  • Exhibit 127: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 128: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 129: Research methodology
  • Exhibit 130: Validation techniques employed for market sizing
  • Exhibit 131: Information sources
  • 11.5 List of abbreviations
  • Exhibit 132: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on End-user - Market share 2021-2026 (%)
  • Exhibits25: Data Table on End-user - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by End-user
  • Exhibits27: Data Table on Comparison by End-user
  • Exhibits28: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Contract research organization - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Contract research organization - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Contract research organization - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Contract research organization - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Business process outsourcing - Market size and forecast 2021-2026 ($ million)
  • Exhibits37: Data Table on Business process outsourcing - Market size and forecast 2021-2026 ($ million)
  • Exhibits38: Chart on Business process outsourcing - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Business process outsourcing - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Market opportunity by End-user ($ million)
  • Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits44: Chart on Geographic comparison
  • Exhibits45: Data Table on Geographic comparison
  • Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on France - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Market opportunity By Geographical Landscape ($ million)
  • Exhibits83: Impact of drivers and challenges in 2021 and 2026
  • Exhibits84: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits85: Overview on factors of disruption
  • Exhibits86: Impact of key risks on business
  • Exhibits87: Vendors covered
  • Exhibits88: Matrix on vendor position and classification
  • Exhibits89: AB Cube SARL - Overview
  • Exhibits90: AB Cube SARL - Product / Service
  • Exhibits91: AB Cube SARL - Key offerings
  • Exhibits92: ArisGlobal LLC - Overview
  • Exhibits93: ArisGlobal LLC - Product / Service
  • Exhibits94: ArisGlobal LLC - Key offerings
  • Exhibits95: BaseCon AS - Overview
  • Exhibits96: BaseCon AS - Product / Service
  • Exhibits97: BaseCon AS - Key offerings
  • Exhibits98: Ennov - Overview
  • Exhibits99: Ennov - Product / Service
  • Exhibits100: Ennov - Key news
  • Exhibits101: Ennov - Key offerings
  • Exhibits102: EXTEDO GmbH - Overview
  • Exhibits103: EXTEDO GmbH - Product / Service
  • Exhibits104: EXTEDO GmbH - Key news
  • Exhibits105: EXTEDO GmbH - Key offerings
  • Exhibits106: Honeywell International Inc. - Overview
  • Exhibits107: Honeywell International Inc. - Business segments
  • Exhibits108: Honeywell International Inc. - Key news
  • Exhibits109: Honeywell International Inc. - Key offerings
  • Exhibits110: Honeywell International Inc. - Segment focus
  • Exhibits111: Indegene Pvt. Ltd. - Overview
  • Exhibits112: Indegene Pvt. Ltd. - Product / Service
  • Exhibits113: Indegene Pvt. Ltd. - Key news
  • Exhibits114: Indegene Pvt. Ltd. - Key offerings
  • Exhibits115: Oracle Corp. - Overview
  • Exhibits116: Oracle Corp. - Business segments
  • Exhibits117: Oracle Corp. - Key news
  • Exhibits118: Oracle Corp. - Key offerings
  • Exhibits119: Oracle Corp. - Segment focus
  • Exhibits120: Sarjen Systems Pvt. Ltd. - Overview
  • Exhibits121: Sarjen Systems Pvt. Ltd. - Product / Service
  • Exhibits122: Sarjen Systems Pvt. Ltd. - Key offerings
  • Exhibits123: United BioSource LLC - Overview
  • Exhibits124: United BioSource LLC - Product / Service
  • Exhibits125: United BioSource LLC - Key offerings
  • Exhibits126: Inclusions checklist
  • Exhibits127: Exclusions checklist
  • Exhibits128: Currency conversion rates for US$
  • Exhibits129: Research methodology
  • Exhibits130: Validation techniques employed for market sizing
  • Exhibits131: Information sources
  • Exhibits132: List of abbreviations